This dataset presents the mitochondrial genome variants associated with oncocytic tumors. These data were obtained by Sanger sequencing of the whole mitochondrial genomes of oncocytic tumors and the adjacent normal tissues from 32 patients. The mtDNA variants are identified after compared with the revised Cambridge sequence, excluding those defining haplogroups of our patients. The pathogenic prediction for the novel missense variants found in this study was performed with the Mitimpact 2 program.
The whole mitochondrial genomes from the tumor tissues were sequenced, the variations were identified by comparing sequences with the revised Cambridge sequence (rCRS) (GenBank number NC_012920); the predictions for pathogenicity of mtDNA variants were established according to the Mitimpact 2 program.
Data source location
Wenzhou, China
Data accessibility
The data are available with this article
Value of the data
The data identified inherited mtDNA variants associated with patients with oncocytic tumors. The data showed some identified mtDNA variants could have functional consequences. The data might help to detect new genetic predisposition markers for oncocytomas.
Data
The data were presented as tables, where positions, detail changes (Table 1) , and the implications were provided (Table 2 ).
Experimental design, materials and methods
We collected 32 cases of the parafin-bedded tissues with oncocytic tumor and matched adjacent normal tissues, mtDNA were amplified by PCR using 24 previously reported pairs of mtDNA primers to cover the whole mtDNA genome as our previous work [1] . MtDNA variants were yielded by comparing sequencing results of the complete mitochondrial genome with the revised Cambridge sequence (rCRS) (GenBank number NC_012920). The heteroplasmy were defined if a double peaks of two residues were verified at the same position in the electro-chromatograms. Pathogenic prediction were analyzed using PolyPhen2 (http://genetics.bwh.harvard.edu/pph2/) [2] and MitImpact 2 [3] . 
The DNA variants detected both in oncocytic tumors and adjacent normal subjects. N, no amino acid change; -, Not applicable; KNP, Known sequence nucleotide polymorphism; Annotation status in Mitomap, the mtDNA variants associated with diseases or being a somatic events in other disease summarised in Mitomap database. 
